All News

Rising Lung Cancer Rates Targets Asian Women Nonsmokers in California

December 13th 2025, 3:00pm

Video

Asian women who do not smoke in Northern California face rising lung cancer rates which are often diagnosed late due to current screening gaps.

Fertility Decisions Influenced by Age and Parental Status in Premenopausal Breast Cancer

December 12th 2025, 10:06pm

Article

Most premenopausal women with early breast cancer accepted GnRHa during chemotherapy to preserve ovarian function; cryopreservation uptake was lower.

Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer

December 12th 2025, 10:01pm

Article

Inluriyo and Verzenio helped patients with ER+/HER2– advanced breast cancer stay on treatment longer without their disease worsening vs standard therapy.

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

December 12th 2025, 8:12pm

Article

The FDA approved Akeega combination therapy for adults with BRCA2-mutated metastatic castration-sensitive prostate cancer.

HRT Use Does Not Raise Breast Cancer Risk in BRCA Carriers

December 12th 2025, 6:11pm

Article

Hormone therapy after breast cancer did not increase risk in BRCA1/2 carriers; estrogen alone was linked to lower risk.

Electronic Intervention Improves Quality of Life in Younger Breast Cancer Survivors

December 12th 2025, 5:10pm

Article

For AYA breast cancer survivors, mobile health intervention was associated with improvements to general and cancer-specific quality of life.

Acupuncture Improves Cognitive Function in Breast Cancer Survivors

December 12th 2025, 4:07pm

Article

Real and sham acupuncture improved perceived cognitive function versus usual care, with real acupuncture showing greater benefits for objective cognitive outcomes.

Suleika Jaouad, Reporting From the Front Lines of Leukemia

December 12th 2025, 2:00pm

Video

Emmy-winning journalist and author Suleika Jaouad recently delivered the keynote address at the inaugural Blood Cancer Heroes celebration.

FDA Grants Priority Review for Opdivo Combo in Advanced Lymphoma

December 12th 2025, 5:00am

Article

The FDA granted review to a supplemental biologics license application for Opdivo plus chemo for previously untreated stage 3/4 classical Hodgkin lymphoma.

Knowledge Isn’t Enough When Action Costs Too Much

December 11th 2025, 10:00pm

Article

I struggle to understand why people support policies and leaders that make healthcare less affordable and accessible for everyone.